Genetics research at Ohio State could soon lead to personalized cancer vaccines. With the help of new technology, experts are able to use genetic sequencing to characterize patients’ cancer cells as well as their genes. With all of that information, doctors can gain better understanding of patients’ immune systems, opening the possibility of personalized vaccines. “We’re developing vaccine approaches to treat patients and help them reject their cancers,” Sameek Roychowdhury, MD, PhD, says. “Genetics is becoming critical to this process.”